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CHROMOSOME studies on invasive tumours have shown that in general each
possesses a unique abnormal karyotype. There is little information at present
on the course of development of malignant cells with abnormal karyotypes from
diploid cells. It is perhaps from those lesions described as carcinoma-in-situ and
other lesions which may have a malignant potential (including some histologi-
cally benign or " atypical " polyps and hyperplasias), as well as from those malig-
nant lesions which show the earliest invasive changes, that information relating
to the importance of chromosomes in the malignant transformation might be
obtained.
A comparative study is therefore in progress of normal endometrium, endo-
metrium showing benign pathological conditions and carcinoma of the endo-
metrium. This report describes the chromosome findings on 7 cases of carcinoma
of the corpus uteri having modal chromosome numbers in the range of 46-49,
andpreliminaryresults on 67specimensofnon-malignant endometrium. Tumours
in the near-diploid range were chosen for study since these might be expected to
show least deviation from the normal karyotype, and any common pattern might
be most clearly revealed. DNA measurements suggest that most carcinomas of
the corpus uteri in fact fall in the diploid range (Atkin, 1966). The tumours
were selected on the basis of quality of chromosome preparations from 31 near-
diploid tumours which form the majority ofa series of 35 carcinomas ofthe corpus
uteri (of the remaining 4, 2 showed both near-diploid and near-tetraploid modes
and 2 showed near-triploid modes).
Observations were made on the untreated specimens; all the patients received
from 1-3 Stockholm radium or Cobalt-60 insertions followed after an interval
of 1-11 weeks by hysterectomy. Particular attention was paid to the depth of
myometrial invasion shown by any residual tumour seen in the hysterectomy
specimen.
MATERIALS AND METHODS
Tumour material obtained by endometrial curettage was divided as follows:
(1) Part was fixed in 10% formol saline for routine histological study.
(2) A small piece was fixed in acetic alcohol; from this, an orcein squash
preparation was made and examined for the presence of tumour, and especially
for the frequency of tumour metaphases. Sex chromatin was evaluated in
tumour interphase cells on a second well-flattened orcein squash preparation.
(3) The remainder was pretreated for chromosome studies by a direct method
similar to that previously described (Atkin and Baker, 1966). The less wellMARION C. BAKER
differentiated tumours have been found to yield more satisfactory results when
exposed to hypotonic solution for only 15 minutes.
The uteri removed after radiation therapy were examined macroscopically,
and areas showing possible residual tumour were chosen for histological examina-
tion. When no tumour was apparent, samples from each cornu and the anterior
and posterior wall were examined histologically for tumour, including evidence
of radiation-destroyed tumour in the form of non-viable tumour giant cells.
To exclude any possible constitutional chromosome anomaly, the karyotypes
of normal leucocytes from each patient were studied in cultures derived from
either an uninvaded pelvic lymph node removed at hysterectomy or peripheral
blood.
Curettings from non-malignant cases were pretreated for chromosome studies
by a similar direct technique, provided that preliminary examination of an orcein
squash preparation showed a sufficient number ofmitoses in the epithelium.
RESULTS
Case 1
Aged 52. Endometrial curettings showed a moderately well-differentiated
adenocarcinoma. Treatment consisted of 2 Cobalt-60 insertions with a week's
interval in between, followed 7 weeks later by panhysterectomy. Histological
examination showed considerable radiation changes in the uterus and ovaries
but no evidence of neoplastic growth in the uterus, tubes, ovaries or lymph nodes.
The patient was well 15 months later.
Chromosome counts on the untreated specimen were as follows:
Chromosome number
42 43 44 45 46 47 Total
No. ofcells 1 1 1 5 12 21 41
Sixteen metaphases with 47 chromosomes were analysed and all showed an
apparent trisomy for a C-group chromosome (Fig. 1). In 2 cells a normal diploid
karyotype was present. Four hypodiploid cells were analysed: 3 metaphases with
45 chromosomes showed loss of a C-, D- and E-group chromosome respectively,
and 1 metaphase with 44 chromosomes lacked a C- and an E-group chromosome.
Case 2
Aged 51. Endometrial curettings showed atypical hyperplastic endometrium
with areas of frank well-differentiated adenocarcinoma. The patient was treated
by 1 Stockholm radium insertion followed 3 weeks later by an extended hysterec-
tomy. Histologically the uterus showed a few areas of grossly atypical endo-
metrial glands but no invasive carcinoma. The patient was well 20 months
later.
Chromosome counts on the untreated specimen showed:
Chromosome number
38 41 45 46 47 Total
No. of cells 1 1 1 7 22 32
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Karyotypes of 13 metaphases with 47 chromosomes showed, as in the previous
case, an apparent trisomy for a C-group chromosome (Fig. 2). This abnormality
was present in 2 cells with 46 chromosomes which also lacked an E-group chromo-
some. Two further metaphases with 46 chromosomes showed normal diploid
karyotypes. Thus 15 of a total of 17 cells analysed carried the apparent C-group
trisomy.
C'ase 3
Aged 53. Endometrial curettage was performed on 2 occasions (at a week's
interval) before treatment, but only tissue from the second specimen was used for
chromosome study. Histologically the first specimen showed a well-differentiated
papillary adenocarcinoma. On the second occasion, both the tissue fixed in
formol saline and a small piece of the material taken for chromosome studies
which was subsequently examined histologically showed only atypical adeno-
matous hyperplasia. Treatment consisted of 2 Cobalt-60 insertions at a week's
interval, followed 11 weeks later by panhysterectomy. Histologically, the uterus
showed a small superficial area of papillary adenocarcinoma, with no invasion of
the myometrium. The patient was well 21 months later.
Chromosome counts on the untreated specimen showed:
Chromosome number
42 43 44 45 46 47 48 50 51 Total
No. of cells 4 1 5 7 14 41 12 5 3 92
A major cell-line with an apparent D-group trisomy was revealed in 33 out
of 35 cells analysed with 47 chromosomes (Fig. 3). Three minor cell-lines with
48 (Fig. 4), 50 and 51 chromosomes show closely related karyotypes which include
the apparent D-group trisomy (Table I).
In addition to those summarised in Table I, 7 cells with either 44 or 45 chromo-
somes were analysed: 5 showed the apparent D-group trisomy; otherwise there
was random chromosome loss from groups C, E, F and G. The metaphases with
46 or 47 chromosomes which differ from the 47 or 48 chromosome cell-lines by
the random loss of one chromosome could represent minor cell-lines, but it seems
more probable that they are members of the 47 and 48 chromosome cell-lines
respectively and have suffered chromosome loss.
Case 4
Aged 58. Two specimens of endometrial curettings were obtained at an
interval of a week before treatment and both showed a well-differentiated adeno-
acanthoma. Clinically the tumour was close to the endocervix but nevertheless
appeared confined to the corpus.
Treatment consisted of 3 Stockholm radium insertions with intervals of 1 and 2
weeks respectively, followed 3 weeks later by Wertheim's hysterectomy. Histo-
logically the uterus showed residual viable adenoacanthoma just commencing
invasion on the posterior endometrial surface. No metastases were found.
Thirty months after initial diagnosis, an emergency resection of a portion of
small intestine for obstruction revealed a malignant stricture which histologically
685MARION C. BAKER
showed moderately differentiated adenocarcinoma similar to that seen previously
inthe corpus uteri.
Chromosome studies were performed on both the untreated specimens; the
chromosome counts are shown below.
Chromosome number
A
<44 44 45 46 47 48 94 Total
FIst Specimen 6 2 2 13 62 11 96
Nc.llf 2ndSpecimen 2 3 3 4 19 4 1 36
L Total 8 5 5 17 81 15 1 132
Analysis of metaphases from each specimen showed no significant difference
and the findings have therefore been pooled in Table I.
At least 3 related cell-lines having 46, 47 and 48 chromosomes respectively
appear to be present in this tumour. The major cell-line has 47 chromosomes;
its karyotype contains a submetacentric marker chromosome longer than the
No. 1 chromosomes, other changes being the addition of a C- and an F-group
chromosome and the loss of a No. 2 and a No. 16 chromosome (Fig. 5). Most of
the cells with 46 chromosomes showed a similar karyotype including the marker
chromosome but without the additional F-group chromosome (Fig. 6), and they
probably represent a distinct but related cell-line. The same may be true of the
3 cells with 48 chromosomes which had the same karyotype as the 47 chromosome
cell-line with a second additional C-group chromosome.
In addition to those summarised in Table I, 2 metaphases with less than 46
chromosomes which may have suffered chromosome loss were analysed. A cell
with 45 chromosomes showed the submetacentric marker chromosome but had
lost a No. 2 and No. 16 chromosome. A metaphase with 44 chromosomes differed
from the 47 chromosome cell-line in lacking a No. 3, a second E-group and a G-
group chromosome. The cells with 46 or 47 chromosomes whose karyotypes differ
from that of the majority with the same chromosome numbers might represent
further minor cell-lines, but it seems more probable that they are incomplete
cells, analysis showing that they lacked one chromosome as compared with one
or other ofthe 3 distinct cell-lines.
Comparative measurements of the long marker chromosome and the single
apparently normal No. 2 chromosome in 10 metaphases from the 47 chromosome
cell-line showed that the mean arm ratio of the markers was 1f96 (standard
deviation ± 0-22) while that of the apparently normal No. 2 chromosomes was
1*56 (standard deviation i 0.17); the mean length ofthe markers relative to that
ofthe No. 2 chromosomes was 1.24 (standard deviation + 0.08). In comparison,
the mean arm ratios of the two No. 2 chromosomes in 8 diploid metaphases from
the series of non-malignant endometria (estimating the average ratio for the
chromosome in each cell with the longer arm ratio, and that for the chromosome
with the shorter arm ratio) was 1-65 (standard deviation ± 0.18) and 1-56 (stan-
dard deviation + 0.13) respectively; the mean ratio of the lengths of these No. 2
chromosomes (longer chromosome/shorter chromosome) was 1*04 (standard
deviation ± 0.06). The No. 2 chromosomes in 3 diploid metaphases from this
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patient's leucocyte culture had the following arm ratios (the first figure refers to
the longer chromosome, and the ratio of the length of the longer to that of the
shorter chromosome is given in brackets after each pair): 1*70 and 1-60 (1.04);
1-46 and 1-58 (1-03); 1-45 and 1-45 (1.00).
Case 5
Aged 67. Endometrial curettings showed a moderately well-differentiated
columnar cell adenocarcinoma. An extended hysterectomy was performed
1 week after a Stockholm radium insertion. Tumour of similar histological
appearance was present on the posterior wall of the uterus, which it had invaded
to a depth of 7 mm.; tumour was also extending down the cervical canal. No
tumour was present in the parametria, ovaries or pelvic lymph nodes. The
patient waswell 10 months later.
Chromosome counts on the untreated specimen were as follows:
Chromosome number
44 45 46 47 48 49 51 Total
No. ofcells 2 1 2 5 7 33 1 51
A major cell-line with 49 chromosomes whose karyotype shows 3 additional
C-group chromosomes was present in this tumour (Fig. 7). The metaphases
with less than 49 chromosomes which were analysed are probably incomplete
although a minor cell-line with 48 chromosomes showing only 2 additional C-
group chromosomes may be present. There may also be a second minor cell-line
with 51 chromosomes (Table I).
Case 6
Aged 73.-Endometrial curettings showed a well-differentiated papillary
adenocarcinoma. Treatment consisted of 2 Stockholm radium insertions with an
interval of a week followed 4 weeks later by Wertheim's hysterectomy. Histo-
logically, the uterus showed tumour extending to within 6 mm. of the serosal
surface, but no metastases were found. The patient was well 26 months later.
Chromosome counts obtained from the untreated specimen were as follows:
Chromosome number
<40 40 42 43 45 46 Total
No. ofcells 5 2 1 1 9 34 52
Of 23 metaphases analysed with 46 chromosomes, 1 showed an apparently
normal diploid karyotype. The remaining 22 revealed an additional G-group
chromosome and the loss of a No. 16 chromosome (Fig. 8). Five cells with 45
chromosomes showed the same abnormal karyotype less either a D-, a second E-
or an F-group chromosome. A further cell with 45 chromosomes showed only
the loss of a No. 16 chromosome from a diploid karyotype. Thus, of 29 cells
analysed, 27 showed the additional G-group chromosome.
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Case 7
Aged 57. Endometrial curettings showed anundifferentiated adenocarcinoma.
Treatment consisted of a Stockholm radium insertion followed after 2 weeks by
total hysterectomy. Histologically, tumour was found to be extending from the
uterine cavity through the myometrium to the serosal surface, and the deposits
were present in the left ovary and peritoneum. Ten days later, firm discrete
nodes were felt inbothinguinalregionswhich were consideredtocontain metastatic
tumour. The patient was given 2 courses ofexternal radiation but died 9 months
after initial diagnosis.
Chromosome counts from the untreated specimen showed:
Chromosome number
C--
<40 40 42 43 44 45 46 Total
No. ofcells 3 2 1 5 2 7 57 77
Thirty-eight metaphases with 46 chromosomes were analysed. Thirty-six
of these showed an apparently normal diploid karyotype (Fig. 9) but in 2 cells
which perhaps represent a minor cell-line a subtelocentric marker chromosome
larger than the No. 1 chromosome replaced a B-group chromosome (Fig. 10).
Two cells with 45 chromosomes were analysed and showed the loss of a C-group
and an E-group chromosome respectively from a diploid karyotype.
Careful scrutiny of the analysed metaphases for any small but consistent
chromosomal changes revealed only a possibly abnormally large No. 17 chromo-
some pair in 15 ofthe 38 cells with 46 chromosomes, includingthe 2with themarker
chromosome (Fig. 10). It is possible that the apparently normal metaphases
originated from non-malignant epithelium adjacent to the tumour or from the
stroma. However, the tissue used for chromosome studies was homogeneous in
appearance and neither the orcein squash preparation nor the histological sections
showed the presence of any non-malignant endometrium. Very few mitoses
were present in the stroma.
An orcein squash preparation of tumour material from the hysterectomy
specimen revealed many mitoses a large number of which showed evidence of
radiation damage but a chromosome preparation was of poor quality. Speci-
mens of metastatic tumour obtained 24 hours post mortem showed many mitoses
but no countable metaphases were obtained from a chromosome preparation.
A brief report of this case was published previously (Atkin and Baker, 1966).
A single sex chromatin body was present in the interphase cells of all these
tumours. The leucocyte cultures yielded only diploid karyotypes.
Of the 24 near-diploid tumours which yielded less favourable chromosome
preparations, 13 have so far been assessed for the presence of marker chromo-
somes; 6 of these tumours showed at least 1 marker chromosome. These 13
tumours showed a moderately or well-differentiated histological pattern, apart
from 1 tumour (having a marker chromosome) which was poorly differentiated.
Of the 11 tumours in which the presence of a marker chromosome has not yet
been assessed, only 1 was poorly differentiated. Both near-diploid and near-
tetraploid modes were present in 2 further adenocarcinomas. One of these was
poorly differentiated and the other well-differentiated, but only the former showed
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a marker chromosome. The karyotypes of a well-differentiated and a poorly
differentiated adenocarcinoma with chromosome numbers in the range of 60-80
included a marker chromosome. No correlation is so far apparent between the
modal chromosome numbers of these 28 tumours and the depth of myometrial
invasion of residual tumour present in the hysterectomy specimens.
Analysable metaphases were obtained from 67 specimens of non-malignant
endometrium; 47 of these were in the proliferative phase and 20 in the secretory.
Eighteen of the former showed hyperplastic changes, 3 being classified as metro-
pathia. Polypoid changes were present in 7 ofthe 67 cases and areas of atypical
epithelium were seen in 1 case included in the hyperplastic group and in 1 included
in the proliferative group. The analyses are incomplete but none has yielded
chromosome counts greater than 46, although 36 out of the 106 metaphases
analysed so far have counts of between 36 and 45. This hypodiploidy could in
each instance have arisen by the loss of 1 or more chromosomes from a diploid
karyotype. The frequency of hypodiploid metaphases shows no correlation with
the histological pattern oftheendometrium.
DISCUSSION
The 7 cases of carcinoma of the corpus uteri presented in this study provide
further examples of the diversity of karyotype to be found even among a group
of tumours from the same site and with similar chromosome numbers.
Both Cases 1 and 2 showed an apparent C-group trisomy and may therefore
have undergone an identical chromosome change; however, it is possible that the
extra chromosome is different in the 2 tumours and, in either or both, could be
an abnormal chromosome, perhaps derived from chromosomes of groups other
thanC-group.
A further important finding in all 7 cases is the presence ofan identical karyo-
type in the majority of the metaphases from each tumour. This supports the
hypothesis that all the cells within a tumour commonly arise from 1 cell with an
abnormalkaryotype.
EXPLANATION OF PLATES.
FIG. 1.-Case No. 1.-Karyotype ofmetaphase with 47 chromosomes showing a C-group trisomy.
FIG. 2.-Case No. 2.-Karyotype ofmetaphase with 47 chromosomes showing a C-group trisomy.
FIG. 3.-Case No. 3.-Karyotype ofmetaphase from the major cell-line with 47 chromosomes
showing a D-group trisomy.
FIG. 4.-Case No. 3.-Karyotype ofmetaphase with 48 chromosomes showing a C- and D-group
trisomy.
FIG. 5.-Case No. 4.-Karyotype of metaphase from the major cell-line with 47 chromosomes
showing an additional C- and F-group chromosome and the loss of a No. 16 chromosome.
The marker chromosome (arrowed) replaces a No. 2 chromosome.
FIG. 6.-Case No. 4.-Karyotype of metaphase with 46 chromosomes showing an additional
C-group chromosome and the loss of a No. 16 chromosome. The marker chromosome
(arrowed) replaces a No. 2 chromosome.
FIG. 7.-Case No. 5.-Karyotype of metaphase with 49 chromosomes showing 3 additional
C-group metaphases.
FIG. 8.-Case No. 6.-Karyotype of metaphase with 46 chromosomes showing the loss of a
No. 16 chromosome and the addition of a G-group chromosome.
FIG. 9.-Case No. 7.-Karyotype of metaphase with 46 chromosomes showing an apparently
diploid karyotype.
FIG. 10.-Case No. 7.-Karyotype of metaphase with 46 chromosomes showing the marker
chromosome (arrowed) replacing a B-group chromosome and including the possibly abnor-
mally large No. 17 chromosome pair.
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A fewr cells with differing but closely related karyotypes have beeni fouind in
each tumour. Some of these may represent divergent cell-lines but others may
have resulted from chromosome loss due to cell breakage. The metaphases from
C'ases 1, 2, 3 and 6 which show a diploid karyotype may have originated from
adjacent non-malignant epithelium or from the stroma. However, in Cases 1,
2 and 3 whose tumour cell-lines showed only additional morphologically normal
chromosomes to an otherwise diploid karyotvpe the apparently normal metaphases
could be incomplete tumour cells.
Several workers have formulated the clonal evolution theorv according to
which the malignant cell population develops through a number ofstages iilvolving
chromosomal changes (Ford and Clarke, 1963; Lejeune, Berger, Haines, Lafour-
cade, Vialatte, Satge and Turpin, 1963; and de Grouchy, de Nava and Bilski-
Pasquier, 1965). The divergent cell-lines in Cases 3, 4, 5 and 7 may represent
new clones derived from the major cell-line, or alternatively earlier clones from
which the major cell-line has evolved. In Cases 1, 2 and 6 less than 30 cells wAere
analvsed, perhaps too few to reveal the presence of any variant cell-lines.
In Case 3. most of the metaphases showed only an apparent D-group trisomy,
and the cells with 48, 50 and 51 chromosomes may have been derived from this
line by the sequential addition of 1 or 2 chromosomes. Lejeune et al. (1963)
described in a trisomic mongol the acquisition by the leukaemnia cells of a super-
numarv chromosome which was then duplicated; this was followed by the acquisi-
tion of further additional chromosomes which were in turn duplicated, thus givilng
rise to the major 54-chromosome cell line. de Grouchy, de Nava and Bilski-
Pasquier (1965) have found evidence of a similar stepwise evolutionary pattern
in 2 cases of chronic myeloid leukaemia. It is possible that a similar process of
clonal evolution was occurring in the tumour of Case 3 at the time of )resentation
for treatment.
In Case 4 the 46- and 48-chromosome cell-lines differed by I chromiiosome
frorn the major cell-line with 47 chromosomes. The 47-chromosome cell-line
might have developed either from the 46-chromosome cell-line or directly from a
diploid cell; in the latter case, the 46-chromosome cell-line may have arisen from
the 47-chromosome cell-line by the loss of an F-group chromosome. The 48-
chromosome cell-line probably evolved directly from the 47-chromosome cell-linie
by the addition ofa C-group chromosome.
In Case 5 a minor cell-line with 48 chromosomes may have beeil }reseiit from
which the major cell-line with 49 chromosomes could have evolved by the addition
of a C-group chromosome. The I cell with 51 chromosomes may represent a
further step in the evolution of this tumour.
It is probable that non-disjunction led to the acquisition of the additioinal
morphologically normal chromosomes present in the karyotypes of Cases 1-5,
but endoreduplication could also have been responsible. Evidence for endo-
reduplication of a single chromosome in metaphases derived from normal fibroblast
cultures (Lejeune, Berger and Rethore, 1966) and from a 48-hour marrow culture
from a case of multiple myeloma (de Grouchy. de Nava, Bilski-Pasquier. Zittoun
and Bernadou 1967) has been presented.
In the abnormal karyotype of Case 6 there appear to be an extra G-group
chromosome and a missing No. 16 chromosome, but one of the chromosomes
placed in G-group could be the missing No. 16 chromosome which has suffered a
deletion. In one of a series of 7 nephroblastomas, Cox (1966) found a pseudo-
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diploid karyotype, a No. 1 chromosome being apparently replaced by a C-group
chromosome; he suggested that the latter was in fact a No. 1 chromosome which
had suffered a deletion. Structural changes have also evidently occurred in the
evolution of the abnormal karyotype present in Case 4, and in the 2 cells of Case 7
which show a marker chromosome and perhaps represent a developing clone.
The majority of the cells in Case 7 had an apparently normal diploid chromo-
some complement, although it is possible that a chromosome change had occurred
which did not alter the final appearance ofthe karyotype, such as the substitution
of a chromosome by another of similar appearance or a deletion or duplication
too small to be detectable. Reports of apparently normal karyotypes in uncul-
tured material from malignant tumours are few. Cox (1966) has described 3
nephroblastomas with diploid karyotypes. Miles (1967a) has reported a similar
finding in a neuroblastoma, and in a lymph node metastasis from a carcinoma of
the breast (Miles, 1967b). A nephroblastoma under investigation in this labora-
tory also appears to have a diploid karyotype. Curcio (1966), studying a granu-
losa-cell tumour of the ovary, found only diploid karyotypes in the tumour cells
analysed from the primary lesion, omental metastases and ascitic fluid.
In the present series, a marker chromosome was only found in Case 4 and in
2 cells from Case 7. Wakonig-Vaartaja (1962) described a well-differentiated
adenocarcinoma ofthe corpus uteri with a modal chromosome number of 46 whose
karyotype included a submetacentric marker chromosome approximately twice
as long as the single No. 1 chromosome. In a further series of carcinomas of the
corpus uteri, Wakonig-Vaartaja (1963) described 4 cases with near-diploid chromo-
some numbers. Variable chromosomal alterations, including a few marker
chromosomes, were present in the first case, a well-differentiated adenocarcinoma.
One cell was analysed from a second case, a moderately-differentiated adeno-
carcinoma; it had 50 chromosomes and its karyotype showed only an additional
No. 2 chromosome and 3 additional C-group chromosomes. A third case, a
well-differentiated adenocarcinoma showed a modal chromosome number of 46;
one metaphase analysed revealed a diploid karyotype, but it was considered
possibly to be a non-malignant cell.
Recently, Katayama and Jones (1967), in a study of 5 carcinomas ofthe corpus
uteri, reported the presence of 2 marker chromosomes, the first being similar to a
B-group chromosome with a deleted short arm and the second a centric fragment,
in a grade 4 anaplastic adenocarcinoma with chromosome numbers in the range
of 55-61. A second case, a grade 1 well-differentiated adenocarcinoma with
chromosome numbers in the range of 47-52, showed only additional C- and
E-group chromosomes. No karyotype details were given of the other 3 cases in
this series; 2 of these, a grade 2 adenoacanthoma and a grade 4 adenosquamous
carcinoma, had hyperdiploid chromosome numbers, whilst the third case, an
adenocarcinoma grade 3 showed chromosome numbers varying from 47 to 68.
Fischer, Golob and Holzner (1966) have described 2 adenocarcinomas of the
corpus uteri with modal chromosome numbers of 32 and 59 respectively. Only
1 karyotype (from the latter tumour) was depicted; it showed 3 marker chromo-
somes. Curcio and Sartori (1966) have described 2 carcinomas of the corpus
uteri with hypodiploid and hypotriploid modal chromosome numbers respectively,
but no details of the karyotypes were given. An endometrial carcinoma with a
modal chromosome number of 74, with marker chromosomes, was described by
Paulete-Vanrell and Comacho de Osorio (1966).
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Preliminary data on the remaining 28 tumours of the corpus uteri from the
series of 35 being studied in this laboratory, most ofwhich yielded less satisfactory
chromosome preparations, have shown marker chromosomes of variable morpho-
logy to be present in some, and suggest that marker chromosomes may be more
frequently found in poorly-differentiated tumours and in those with higher
chromosome numbers; this is also supported by the findings of the other workers
described above.
Lamb (1967), in a series of transitional-cell carcinomas of the bladder, found
that near-diploid chromosome counts predominated in tumours with a well-
differentiated histological pattern but the majority of these were classified as
in-sitU& carcinomas. Most of the invasive tumours were either moderately well-
differentiated with near-tetraploid modal chromosome numbers or undifferentiated
withnear-triploid modes. No correlation was evident amongthe invasivetumours
between modal chromosome number and depth of invasion; a similar lack of
correlation has so far been found in the present series of carcinomas ofthe corpus
uteri.
No relationship is apparent between the karyotypes ofthe 7 tumours presented
in detail in this study and their degree of differentiation. It may however be
significant that the hysterectomy specimens of Cases 1 to 3, which were the only
ones which showed a single additional morphologically normal chromosome in
their major cell-lines, revealed no histological evidence of myometrial invasion
by residual tumour. It has been suggested that any endometrial carcinoma
confined to the endometrium should be regarded as carcinoma-in-sitUt (Koss and
Durfee, 1961). Such a description would apply to Cases 1 to 3. The curettings
obtained before treatment from Case 2 showed areas of atypical hyperplasia as
well as adenocarcinoma, and the metaphases that were analysed could have
originated from either ofthese. A similar possibility exists for Case 3: the tissue
used for chromosome studies showed only atypical adenomatous hyperplasia but
previous curettings and the subsequent hysterectomy specimen both showed
adenocarcinoma. However, in the present series of 67 non-malignant endometria,
which includes 2 cases with atypical epithelial changes, 3 of metropathia and 18
ofhyperplasia, no chromosome abnormalities have so far been found. Bowey and
Spriggs (1967) in a study of non-malignant endometria also found only normal
karyotypes apart from hypodiploidy due to inconsistent chromosome loss.
Wakonig-Vaartaja (1963) in a study of 16 similar cases found normal karyotypes
in the majority of the cells analysed and considered the variations to have arisen
during preparation. Curcio and Sartori (1966) have studied 2 cases ofendometrial
hyperplasia, but only 9 cells, from 1 of the cases, were analysed; all were diploid.
Wagner, Richart and Terner (1967) have reported finding a wide range of
high interphase DNA values in some endometria showing only glandular hyper-
plasia. It is difficult to relate these results on the one hand to the absence of
chromosome abnormalities in non-malignant endometrium and on the other to
the minimal changes (in most metaphases, trisomy for a single chromosome)
found in the 3 tumours in the present series showing only stromal invasion.
Several malignant or premalignant lesions in which trisomies were the only
chromosomal alterations have been reported. A D-group trisomy was present
in the myeloma cells of the case mentioned above showing possible selective
endoreduplication (de Grouchy et al., 1967). C-group trisomy has been reported
as the only chromosomal abnormality in the bone marrow of a patient with
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"atypical myeloproliferative disorder" (Winkelstein, Sparkes and Craddock.
1966), one with myeloid metaplasia and possible leukaemia (Sandberg, Ishihara
and Crosswhite, 1964), and one with atypical chronic granulocytic leukaemia
(Speed and Lawler, 1964). A C-group trisomy alone has also been reported in
several cases ofacute myeloid leukaemia (Hungerford and Nowell, 1962 Weinstein
and Weinstein, 1963; Sandberg, Ishihara, Kikuchi and Crosswhite, 1964), and,
in additioni to the Philadelphia (Ph1) chromosome, ill several cases of chronic
rnyeloid leukaemia (Goh, Swisher and Trou), 1963; Court Brown and Tough.
1963).
Lubs and Kotler (1967) and Enterline and Arvan (1967) have reported aneu-
)loidy in benign polyps of the colon, and 5 similar lesions showing chromosome
anomalies are being studied in this laboratory. The karyotypic alterations are
usually in the form of additional morphologically normal chromosomes. Two of
the 17 polyps studied by Enterline and Arvan showed a C- and D-group trisomv
respectively in the majority ofthe cells analysed. However. Enterline and Arvan
found 1 or 2 marker chromosomes in 5 out of the 7 polyps that showed epithelial
atypia and the karyotype of one of the polyps being studied in this laboratory,
which shows moderate atypia in both adenomatous and villous areas. includes a
ring chromosome possibly derived either from a No. 1 or No. 3 chromosome.
Chromosome abnormalities including marker chromosomes have also been reported
in several cases of carcinoma-in-situ. and dysplasia of the uterine cervix (Atkin
and Baker, 1965; Auersperg, Corey and Worth, 1967; Boddington, Spriggs and
Wolfendale, 1965; and Wakonig-Vaartaja and Kirkland. 1965). A view which
would be consistent with the above findings on the colon and cervix uteri is that
carcinomas of the corpus uteri which show only stromal invasion are at a stage
in their evolution, at least as regards their chromosomal status, which is equivalent
to that found in carcinoma-in-situ and dysplasia of the cervix uteri and in appar-
enitly benign polyps of the colon, some at least of which may represent a stage in
the development ofcarcinoma.
SUMMARY
The karyotypes of 7 near-diploid tumours from a series of 35 carcinomas of
the corpus uteri were studied in detail and the findings were related to the degree
of myometrial invasion shown by residual tumour in the uterus at hysterectomy
1 to 11 weeks after intracavity radiation therapy. The majority of the meta-
phases analysed in each tumour showed an identical karyotype, although minor
cell-lines with closely related karyotypes were present in 4 tumours suggesting
that clonal evolution was occurring.
A C-group trisomy (2 tumours) or a D-group trisomy was the only abnormality
in the major cell-line of the 3 tumours which showed no myometrial invasion bv
residual tumour. Of the 4 remaining tumours which showed varying degrees of
myometrial invasion, slightly more complex karyotype changes were found in 3
(a marker chromosome was present in one), but the fourth showed a diploid
karyotype in 36 out of 38 metaphases, the remaining 2 metaphases having a
marker chromosome in place of a B-group chromosome.
Sixty-seven specimens of non-malignant endometrium showed no evidence of
chromosome abnormality.
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